Neue Suche | Kongressdetail
mail
Druckansicht
 
 

5th NASH Summit 2021

Evvnt Promotion / evvnt
-
29.11.2021 - 02.12.2021  Online
10:00 am - 3:30 pm
 
Kongressthemen
Masterfully combining the hottest insights on NASH from 65+ strong speaker faculty, including 45+ brand new speakers from the FDA, EMA, Takeda, Eli Lilly, Gilead, Pfizer, AstraZeneca, Ionis, Novo Nordisk and more, the 5th NASH Summit is your best opportunity to unite with fellow NASH drug developers to gain critical updates on the trailblazing research you need to meaningfully reassess your therapeutic approach and optimize your pipeline strategy for the future.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/848618-3?pid=4832

Speakers: Christopher Jones Director of Biology Terns Pharmaceuticals, Elias Papatheodoru Chief Executive Officer Genkyotex and more
 

Anfragen und Anmeldung:

https://go.evvnt.com/848618-2?pid=4832
Frau Kaltrina Kastrati
 
Kategorien
Allgemeinmedizin, Klinische Forschung
Sprache
Englisch
Kongressgebühr
USD 2099.00 - USD 3495.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Ärzte der WeltCharité International AcademynewTreeSwiss Tropical and Public Health InstituteÖsterreichisches Rotes KreuzAMREF - African Medical and Research FoundationÄrztekammer für WienHilfswerk Austria